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A recent paper by Erdemli et al. on this journal reviewed 
the antiviral properties of caffeic acid phenetyl ester 
(CAPE) [1]. Recent literature showed that CAPE has also 
anti-inflammatory and immune-modulatory effects, as like 
as many other plant-derived phenolics [2] but its ability to 
exert an anti-inflammatory role has never been assessed in 
clinical trials, therefore, its activity on humans appears only 
presumptive. Yet, biomedical literature about CAPE effect on 
chronic inflammation and cancer appears quite promising and 
should encourage randomized controlled trials in patients. 
Its ability to affect in-vitro tumors is not so far than many 
other plant-derived phenolics, considered as anti-NF-κB 
agents [3], yet its antiviral potential might be attributed to 
independent pathways from interferon (IFN) induced by virus 
entry [4]. If CAPE is described only as an inhibitor of NF-κB 
activation, then some controversial issues would be raised. It 
is well-known that cells activate host-pathogen interactions, 
through the recognition of pathogen-associated molecular 
patterns by host sensors, which were defined as pattern 
recognition receptors. They include toll-like receptors (TLRs), 
RIG-I-like receptors (RLRs), NOD-like receptors (NLRs), and 
DNA receptors. Then, virus may trigger these innate immune 
receptors. In the cell response, the activation of the nuclear 
factor-κB (NF-κB) transcription pathway is crucial for the 
immediate early step of immune activation. However, there 
are a variety of viral effectors that have been shown to prevent 
NF-κB signalling, namely, they should act as polyphenols at 
least three different levels: (a) TLRs, IκB kinase complexes 
and at the transcriptional level [5]. The antiviral activity of 
CAPE might be more complex than expected, therefore, as 
it might interfere with innate immunity as like as viruses, 
if it should act only on NF-κB, even by preventing its 
activation [5]. Which are the major targets of CAPE within 
an infected or inflamed cell? The paper by Erdemli et al. 
report some interesting suggestions [1]. Further consideration 
should be made.
As many other phenol-bearing molecules from plant 
biochemistry, CAPE should exert a protective role for plants and 
a proto-toxic activity in animals. CAPE has been described in 
the past to possess a prooxidant activity [6], particularly in the 
range 1.0-0.5 μM, interestingly the same range reported for its 
antiviral potential [4]. This apparently contradictory evidence, 
where CAPE is both a pro-oxidant and an antiviral molecule, 
deserves further considerastion about the many targets of 
CAPE activity and its pleiotropism within a defined cell. The 
paper by Erdemli et al. did not fully address this concern but 
expanding the debate may be of major interest to shed a light 
on the role of CAPE in propolis. The relationship with the 
redox machinery should involve also mitochondria, which 
activate mitochondria antiviral signaling (MAVS) regulome 
during their mitochondrial dynamics [7]. Mild induction of 
oxidative redox species, triggered by xenobiotics such as plant 
phenolics, may impair MAVS regulome and then activate a 
stress response from infected cells: This speculative hypothesis 
would suggest that CAPE may act, even indirectly, on signaling 
molecules upstream of IFN regulatory factor 3 (IRF-3), which 
are modulated by redox-dependent processes, and include 
MAVS and the tumor necrosis factor receptor-associated factors 
adaptors, all of which are sensitive to redox regulation [8]. 
CAPE is yet able to suppress IRF-3 activation, following 
inflammation or innate immune response [9] but this activity 
may follow cell regulation of virus infection, which allows that 
the E3 ubiquitin ligase RBCC protein interacting with PKC1 
(RBCK1) binds to IRF-3 and targets it for ubiquitination and 
subsequent degradation through a proteasome-dependent 
pathway, to dampen the overexpression of RBCK1 by virus 
and reduce side effects as autoimmune disorders due to the 
excessive activity of IFNs [10]. It is presumable that a fine 
regulation of ROS-response at the mitochondrial turnover 
and MAVS regulome, induced by sub-micromolar doses of 
CAPE, may induce initially an IRF-3 mediated signaling by a 
mild-oxidative stress, inducing intracellular IFN, which then 
rapidly disappears while CAPE still acting on the redox system 
to activate antioxidant scavenging systems. Incubation times 
settled in in-vitro experimental research may hamper the ability 
to gain insights about the first minutes of activity of the natural 
compound, of which we can retrieve evidence mainly regarding 
its anti-oxidant potential and its anti-NF-κB action, while it 
is possible that the early action exerted by these phenolics 
targets fine equilibria involving mitochondria dynamics and 
their relationship with oxidative stress, even stimulating early 
IFN action.
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